Our Social Media

#PMWC18 Chair G.Sledge @StanfordMed shares sneak peek upcoming conference #precisionmedicine #AI #microbiome#AllofUs ow.ly/E75b30f7T1K

L.Hood @Prov_Health talks about transforming #healthcare w/systems approaches to studying disease & #bigdata ow.ly/PL8d30ff8bu #PMWC17

G.Sledge @StanfordMed #PMWC18 Chair: Re cancer we have to be careful not to just focus on the “turning points” ow.ly/VQ5J30f7SK6

Dr.E.Kim #biomarker-based approaches propelled the field - optimize efficacy, reduce toxicity ow.ly/S5IM30f4gUh #PMWC18

.@TempusLabs works on identifying personalized therapies for #cancer, partners w/ @CleClinicMD ow.ly/puUH30fbnk5 speaker #PMWC18 #AI

Emily Leproust, @TwistBioscience and her talk at #PMWC17: "Can Synthetic DNA Solve Humanity's Grand Challenges" ow.ly/37Yy30eB3wR

James Allison @MDAndersonNews provides an overview of where we are with #immunotherapy and why its needed at #PMWC17 ow.ly/zcAl30eB2Pb

Dr.E.Kim, Levine Cancer Institute & speaker #PMWC18: how they address current needs for #cancer care ow.ly/V4AK30f4g6S

Gritstone Oncology, winner of #PMWC17 Company Competition, raises $93 Million bit.ly/2xak2QD #immunotherapy #Cancer

test Twitter Media - Gritstone Oncology, winner of #PMWC17 Company Competition, raises $93 Million https://t.co/GVRNbtZCTJ #immunotherapy  #Cancer https://t.co/VdZZaHiqHF

Universal sequencing may detect more potentially clinically significant heritable mutations #cancer bit.ly/2gOBqUL #PMWC18

test Twitter Media - Universal sequencing may detect more potentially clinically significant heritable mutations #cancer https://t.co/2NntFEg1wS #PMWC18 https://t.co/sPmMM1DbaC

#PMWC18 Chair G.Sledge @StanfordMed shares sneak peek upcoming conference #precisionmedicine #AI #microbiome#AllofUs ow.ly/E75b30f7T1K

L.Hood @Prov_Health talks about transforming #healthcare w/systems approaches to studying disease & #bigdata ow.ly/PL8d30ff8bu #PMWC17

G.Sledge @StanfordMed #PMWC18 Chair: Re cancer we have to be careful not to just focus on the “turning points” ow.ly/VQ5J30f7SK6

Dr.E.Kim #biomarker-based approaches propelled the field - optimize efficacy, reduce toxicity ow.ly/S5IM30f4gUh #PMWC18

.@TempusLabs works on identifying personalized therapies for #cancer, partners w/ @CleClinicMD ow.ly/puUH30fbnk5 speaker #PMWC18 #AI

Emily Leproust, @TwistBioscience and her talk at #PMWC17: "Can Synthetic DNA Solve Humanity's Grand Challenges" ow.ly/37Yy30eB3wR

James Allison @MDAndersonNews provides an overview of where we are with #immunotherapy and why its needed at #PMWC17 ow.ly/zcAl30eB2Pb

Dr.E.Kim, Levine Cancer Institute & speaker #PMWC18: how they address current needs for #cancer care ow.ly/V4AK30f4g6S

Gritstone Oncology, winner of #PMWC17 Company Competition, raises $93 Million bit.ly/2xak2QD #immunotherapy #Cancer

test Twitter Media - Gritstone Oncology, winner of #PMWC17 Company Competition, raises $93 Million https://t.co/GVRNbtZCTJ #immunotherapy  #Cancer https://t.co/VdZZaHiqHF

Universal sequencing may detect more potentially clinically significant heritable mutations #cancer bit.ly/2gOBqUL #PMWC18

test Twitter Media - Universal sequencing may detect more potentially clinically significant heritable mutations #cancer https://t.co/2NntFEg1wS #PMWC18 https://t.co/sPmMM1DbaC